Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

Antiplatelet therapies are commonly used in neurointerventional procedures. However, specific guidelines for their use in these settings is lacking and it can often be difficult to balance the potential risks and benefits of these medications. Considering the continued growth and adoption of neurointerventional procedures, it is crucial to understand the properties of these agents in order to use them safely. Large-scale clinical trials are still needed to clarify many of these aspects for this emerging field. However, the existing literature already provides insight into which antiplatelet drugs are of benefit to the neurointerventionalist as well as their associated risks of ischemic and hemorrhagic complications. Hence, this review focuses on the applications of GPIIb/IIIA inhibitors to neurointerventional procedures.


Davide Simonato, Robin J Borchert, Marc-Antoine Labeyrie, Maurizio Fuschi, Lucie Thibault, Hans Henkes, David Fiorella, Benjamin Yq Tan, Leonard Ll Yeo, Hegoda Ld Makalanda, Ken Wong, Pervinder Bhogal. Glycoprotein IIb/IIIa inhibitors for the neurointerventionalist. Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences. 2022 Feb;28(1):84-91

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 33947250

View Full Text